Houston, Texas, USA
Houston Research Chemicals • University of Houston • Salarius Pharmaceuticals, LLC • Baylor College of Medicine • The University of Texas Health Science Center, Houston • Michael Debakey Veterans Affairs Medical Center • Brooke Army Medical Center • Avanti Anesthesia • Texas Medical Center • Ascend Ketamine • Brain Health Consultants • Lone Star Infusion, PLLC • St. John Mental Health • The Menninger Clinic
Martha St John, MD, PA
Licensed Psychotherapist • Psychiatric-Mental Health Nurse Practitioner • Psychiatrist MD • Receptionist • Receptionist / Medical Office Administrator • Licensed Psychotherapist • Lead Medicinal Chemist • Director of Chemical Biology and Commercialization • Postdoctoral Associate- Psychedelics, Bioethics and Health Policy
The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression • Low Dose Intravenous Ketamine in Treatment Resistant Depression Patients • Efficacy And Tolerability Of Sub-Anesthetic Ketamine In Postpartum Depression • A Study to Evaluate Ketamine for the Treatment of Rett Syndrome • The UTHealth Ketamine Project • Ketamine for Acute Pain Management After Trauma • Trial of the Rapid Antisuicidal Effects of Intranasal Ketamine in Comorbid Depression and Alcohol Abuse • Comparison of Low-dose Ketamine to Opioids in the Management of Acute Pain in Patients Presenting to the Emergency Department With Long Bone Fractures • Optimization of IV Ketamine for Treatment Resistant Depression • ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD) • Ketamine for Treatment Resistant Late-Life Depression • Double-Blind, Placebo-Controlled Trial of Ketamine Therapy in Treatment-Resistant Depression (TRD) • Conscious Sedation Efficacy of the MKO Melt (Midazolam, Ketamine, Ondansetron) • Sequential Therapy for the Treatment of Severe Bipolar Depression. • Endobronchial Ultrasound Guided Transbronchial Needle Aspiration Performed Under General Anesthesia Versus Moderate Sedation • Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy • Safety and Tolerability Study Comparing Sodium Oxybate Given as an Oral Solution to a Single-blinded Combination of Oral Tablets Plus Oral Solution in Subjects With Fibromyalgia • Safety and Efficacy Study of Xyrem (Sodium Oxybate) in Subjects With Fibromyalgia. • Safety and Efficacy of Xyrem Oral Solution (Sodium Oxybate) Compared With Placebo in Narcoleptic Patients • A Safety and Efficacy Study of Xyrem (Sodium Oxybate) to Treat Fibromyalgia. • Long Term Follow Up Study to COMP 001 And COMP 003 Trials (P-TRD LTFU) • A Multicenter Study of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects With Narcolepsy With Cataplexy • A Safety and Efficacy Study of Xyrem in Subjects With Fibromyalgia